|
Sno.
|
Test Name
|
Amount
|
Min Qty
|
Ref. Value
|
|
1
|
C - PEPTIDE ( PP) |
750 |
1 ml
|
Fasting Values : 1.1 - 4.4. ng/ml.
PP values are higher than the fasting levels and are dependent on the nature of Diet.No separate PP reference values are available.
C-Peptide values are decreased in Type 1 Diabetes Mellitus.
Increased in Hyperinsulinism,Obesity and Renal Insufficiency.
|
|
2 |
C - PEPTIDE ( Random) |
750 |
1 ml
|
|
|
3
|
C - PEPTIDE PROFILE |
2800 |
1 ml
|
|
|
4 |
C - PEPTIDE ( FASTING) |
750 |
1 ml
|
1.1-4.4 ng/ml
C-Peptide values are decreased in Type 1 Diabetes Mellitus.
Increased in Hyperinsulinism,Obesity and Renal Insufficiency.
|
|
5
|
c KIT MUTATION SCREENING - AML |
9000 |
|
|
|
6 |
C- ANCA |
1000 |
500ul
|
|
|
7
|
C.M.V Avidity |
1000 |
|
Low Avidity : Below 30 %
Borderline IgG Avidity : 30 - 40 %
High Avidity : Above 40 %
Detection of a low IgG avidity along with positive IgM & IgG levels is a reliable indicator for Primary (recent) Cytomegalovirus infection. Detection of high IgG avidity along with positive IgG levels shows that the infection has occurred in the past (> 2-4 months).
In some cases, positive Cytomegalovirus IgM antibodies can persist for several months or years after primary infection in an individual. Persistence of low avidity following infection is not uncommon.
Cytomegalovirus Avidity IgG testing results should be interpreted in conjunction with results of Cytomegalovirus IgG and Cytomegalovirus IgM.
In absence of Cytomegalovirus IgG result, avidity testing is inconclusive
|
|
8 |
C.M.V IGG AB (CYTOMEGALO VIRUS) |
350 |
1 ml
|
Less than 0.5 U/ml : Negative
0.5 - 1.0 U/ml : Equivocal
More than or Equal to 1.0 U/ml : Positive
CMV usually causes mild and asymptomatic infections, but may pose a significant medical risk in pregnant women, new born and immunocompromised individuals.
CMV IgG Positive test indicates past or acute infection. BY the age of 25 years most of the population will be positive for CMV IgG.
All results should be interpreted by treating physician with additional relevant diagnostic information and clinical findings.
Precaution: In immunocompromised patients, CMV serology (IgG or IgM antibody titres) may not be reliable and may be misleading in the diagnosis of acute or reactivation of CMV disease. The preferred method for diagnosis is CMV Viral Load Testing.
|
|
9
|
C.M.V IGM AB (CYTOMEGALO VIRUS) |
350 |
1 ML
|
Less than 0.70 COI : Negative
0.70 - 1.00 COI : Equivocal
More than 1.00 COI : Positive
CMV usually causes mild and asymptomatic infections, but may pose a significant medical risk in pregnant women, new born and immunocompromised individuals.
In utero infection can lead to varying degrees of mental retardation, chorioretinitis, hearing loss and neurologic problems.
Equivocal results should be retested after 2 weeks.
Positive test results indicate primary infection, reinfection or reactivation of latent virus. It is recommended to confirm the clinical relevance of reactive results by CMV Viral Load Testing .
All results should be interpreted by treating physician with additional relevant diagnostic information and clinical findings.
|
|
10 |
C.M.V. IGG AB(CSF) |
250 |
|
|
|
11
|
C.M.V. IGM AB (CSF) |
250 |
|
|
|
12 |
C.R.P. |
300 |
0.5 ml
|
Neonates Less than 3 weeks :< 4.1 mg/l
Children 2 months to 15 yrs:< 2.8 mg/l
Adults :Less than 5.0 mg/l
|
|
13
|
C.S.F. CULTURE & SENSITIVITY |
750 |
|
|
|
14 |
C.S.SPINT OPEN MOUTH
|
300 |
|
|
|
15
|
C.SPINE EXTENSION
|
300 |
|
|
|
16 |
C.SPINE FLEXION
|
300 |
|
|
|
17
|
C.SPINE OBLIQUE LEFT
|
300 |
|
|
|
18 |
C.SPINE OBLIQUE RIGHT
|
300 |
|
|
|
19
|
C1 Esterase Inhibitor |
3000 |
|
195 - 345 mg/L
C1 inactivator deficiency is one of the commonest inherited complement deficiencies leading to Hereditary Angioedema. This deficiency is of two types :
1.Type I ( reduced serum levels of functionally active C1 inactivator)
2.Type II (normal or elevated levels of functionally inactive C1 inactivator)
Acquired C1 esterase inhibitor deficiency is rare and all reported cases have been secondary to Lymphomas or Myelomas.
Please Correlate Clinically.
|
|
20 |
C3 (COMPLEMENT C3) |
500 |
1 ml
|
90 - 180 mg/dl
|
|
21
|
C4 ( COMPLEMENT C4) |
500 |
0.5 ml
|
10 - 40 mg/dl.
|
|
22 |
CA 125 |
700 |
1 ml
|
Less than 35.0 U/ml
CA 125 levels are increased in Ovarian Tumours of Epithelail origin. Minor elevations are also seen in Benign Ovarian Cysts, Endometriosis , TB of Abdomen and Pelvic Inflammatory Disease. Please correlate with Clinical and Imaging Data.
|
|
23
|
CA 19 - 9 |
800 |
1 ml
|
0 - 39.0 U/ml
CA 19-9 Levels are increased in Obstructive Jaundice, pancreatitis, Cirrhosis of Liver and very high levels in Carcinoma of Pancrease.
HIgher levels of CA 19 -9 alone cannot be used for Diagnosis of CA.Pancreas and must be correlated with other clinical and imaging data.
Can be used for follow up of Patients after surgery for Pancreatic Carcinoma.
|
|
24 |
CA - 125 ( ASCITIC FLUID) |
500 |
|
No reference value available.
Reference value for Blood : Less than 35.0 U/ml.
|
|
25
|
CA - 15 - 3 |
800 |
1 ml
|
Less than 34.5 U/ml
CA 15-3 Levels should be used only for detection of recurrence in previously treated patients and monitoring response to therapy. Should not be used for Diagnosis or Screening for Breast Cancer. For Diagnosis and screening Clinical Breast examination and mammogram should be used.
Note : Kindly note the changes in reference interval.
|
|
26 |
CA 19 - 9 (PANCREATIC FLUID) |
600 |
|
|
|
27
|
CA 27.29 |
12500 |
|
Less than 38 U/mL
|
|
28 |
CA 72 - 4 |
1700 |
|
5.6-8.2 U/ml
Elevated CA-72-4 levels are primarily used in monitoring treatment and disease course in patients with gastric cancer. In 70% of relapse cases, CA-72-4 increases prior or concurrently with clinical diagnosis of the relapse. Diagnostic sensitivity of CA-72-4 for gastric cancer increases to 66% when combination of CA-72-4,CEA,CA-125 and CA 19-9 are used. Can be elevated in ovarian and colorectal cancer.
Can also be found in certain non-malignant diseases like pneumonia, pancreatitis, liver cirrhosis and ovarian cysts.
|
|
29
|
Cabbage(f216) - SPECIFIC IgE |
600 |
|
Less than 0.35 IU/mL: Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL: Very High Positive
|
|
30 |
CALCITONIN |
4000 |
1 ML
|
Female : 5.17 - 9.82 pg/ml
Male : 8.31 - 14.3 pg/ml
|
|
31
|
CALCIUM - DIALYSIS FLUID |
150 |
|
|
|
32 |
CALCIUM -SERUM |
150 |
0.5 ML
|
Children
0 - 10 Days : 7.6 - 10.4 mg/dl
10 days - 2 yrs : 9.0 - 11.0 mg/dl
2 - 12 yrs : 8.8 - 10.8 mg/dl
12 - 18 yrs : 8.4 - 10.2 mg/dl
Adults
18 - 60 yrs : 8.6 - 10.0 mg/dl
60 - 90 yrs : 8.8 - 10.2 mg/dl
More than 90 yrs: 8.2 - 9.6 mg/dl
|
|
33
|
Calprotectin- Fecal |
3000 |
|
Less than 80.0 ug/g: Normal
80 - 160 ug/g: Gray Zone - repeat test after four weeks.
More than 160 ug/g: Positive
Calprotectin increased in Inflammatory Bowel Disease (IBD), Coeliac disease, infectious Colitis, necrotizing enterocilitis and colorectal cancer. The main IBD's are Ulcerative Colitis and Crohn's disease. Calprotectin usually normal in Irritable Bowel Syndrome (IBS).
False elevation of Calprotectin can be observed in patients taking non-steriodal anti-inflammatory drug (NSAID) and infective gastro enteritis.
|
|
34 |
CALR Mutation Analysis |
6000 |
|
|
|
35
|
Cancer Syndrome Gene Panel |
25000 |
|
|
|
36 |
Candida albicans( m5)- SPECIFIC IgE |
600 |
|
Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
|
|
37
|
CANNABINOIDS(URINE) |
200 |
|
|
|
38 |
CARBAMAZEPINE |
750 |
0.5 ml
|
Therapeutic Level : 4 - 12 Microgm/ml
|
|
39
|
CARDIOLIPIN AB IGA |
600 |
1 ML
|
Less than 12 APL/ml:Negative
12 to 18 APL/ml :Equivocal
More than 18 APL/ml:Positive
|
|
40 |
CARDIOLIPIN AB IGG |
600 |
1 ml
|
Less than 12 GPL/ml:Negative
12 - 18 GPL/ml :Equivocal
More than 18 GPL/ml:Positive
|
|
41
|
CARDIOLIPIN AB IGM |
600 |
1 ML
|
Less than 12 MPL/ml:Negative
12 - 18 MPL/ml :Equivocal
More than 18 MPL/ml:Positive
|
|
42 |
CARNITINE -SERUM |
4500 |
|
|
|
43
|
Carrot (f31) - SPECIFIC IgE |
600 |
|
Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
|
|
44 |
Casein ( f 78)- SPECIFIC IgE |
600 |
|
Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
|
|
45
|
Cat dander ( e100)- SPECIFIC IgE |
600 |
|
Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
|
|
46 |
Cat epithelium( e1)- SPECIFIC IgE |
600 |
|
Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
|
|
47
|
CATECHOLAMINES ( 24 HOURS URINE) |
5500 |
10 ML
|
14 - 110 ug/24hrs
Catecholamines, including dopamine and norepinephrine, are the principal neurotransmitters that mediate a variety of the central nervous system functions, such as motor control, cognition, emotion, memory processing, and endocrine modulation.
Included among catecholamines are epinephrine (adrenaline), norepinephrine (noradrenaline), and dopamine, all of which are produced from phenylalanine and tyrosine.
Release of the hormones epinephrine and norepinephrine from the adrenal medulla of the adrenal glands is part of the fight-or-flight response.
Catecholamines cause general physiological changes that prepare the body for physical activity (fight-or-flight response). Some typical effects are increases in heart rate, blood pressure, blood glucose levels, and a general reaction of the sympathetic nervous system. Some drugs, like tolcapone (a central COMT-inhibitor), raise the levels of all the catecholamines.
|
|
48 |
CATECHOLAMINES ( PLASMA) |
8000 |
|
|
|
49
|
CATECHOLAMINES ( SPOT URINE) |
5500 |
|
|
|
50 |
CATHEPSIN - G |
750 |
|
<1.0 Ratio: Negative
1.0 - 2.0 : Weak positive
2.0 - 5.0 : Positive
>5.0 : High Positive
|
|
51
|
Cauliflower(f291) - SPECIFIC IgE |
600 |
|
Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
|
|
52 |
CBC |
300 |
|
|
|
53
|
CD 38 |
1250 |
|
|
|
54 |
CD 48 |
1250 |
|
|
|
55
|
CD 10 |
1250 |
|
|
|
56 |
CD 117 |
1250 |
|
|
|
57
|
CD 11C |
1250 |
|
|
|
58 |
CD 13 |
1250 |
2 ml
|
|
|
59
|
CD 14 |
1250 |
|
|
|
60 |
CD 15 |
1250 |
|
|
|
61
|
CD 16 |
1250 |
|
|
|
62 |
CD 19 |
1250 |
|
Normal : 8 % to 18 %
Ref : Int.Journal of Immunopathology & Pharmocology 2017 Jun30 (2) 194-200
|
|
63
|
CD 20 |
1250 |
|
Normal : 10 % to 20 %
Ref : Int.Journal of Immunopathology & Pharmocology 2017 Jun30 (2) 194-200
|
|
64 |
CD 200 |
1250 |
|
2 ml EDTA Blood or 2 ml Heparin Blood (Green Top)
|
|
65
|
CD 22 |
1250 |
|
2 ml EDTA Blood or 2 ml Heparin Blood (Green Top)
|
|
66 |
CD 23 |
1250 |
|
|
|
67
|
CD 24 |
1250 |
|
|
|
68 |
CD 25 |
1250 |
|
|
|
69
|
CD 3 |
1250 |
|
|
|
70 |
CD 33 |
1250 |
|
|
|
71
|
CD 34 |
1250 |
2 ml
|
|
|
72 |
CD 41 |
1250 |
|
|
|
73
|
CD 45 |
1250 |
2 ML
|
|
|
74 |
CD 5 |
1250 |
|
|
|
75
|
CD 55 |
1250 |
|
|
|
76 |
CD 56 |
1250 |
|
|
|
77
|
CD 59 |
1250 |
|
|
|
78 |
CD 64 |
1250 |
|
|
|
79
|
CD 7 |
1250 |
|
|
|
80 |
CD4 |
1250 |
|
|
|
81
|
CD4/CD8 COUNT |
1000 |
2 ML
|
|
|
82 |
CD8 |
1250 |
|
|
|
83
|
CEA |
750 |
1 ml
|
Non.Smokers : Upto 5.0 ng/ml
Smokers : Upto 6.5 ng/ml
CEA levels are elevated in Carcinomas of Colon, Lung, Ovaries,Breast, Liver and Pancreas.
CEA levels can be used only for Monitoring and staging of the disease and not for Diagnosis.
|
|
84 |
CEA (ASCITIC FLUID)
|
500 |
|
No reference value available.
|
|
85
|
CEA (CYSTIC FLUID) |
500 |
|
|
|
86 |
CEA (PANCREATIC FLUID) |
400 |
|
|
|
87
|
CELL COUNT ( CYSTIC FLUID) |
60 |
|
|
|
88 |
CELL COUNT ( DIALYSIS FLUID) |
60 |
|
|
|
89
|
CELL COUNT ( PERITONEAL FLUID) |
100 |
|
|
|
90 |
CELL COUNT (ASCITIC FLUID) |
100 |
|
|
|
91
|
CELL COUNT (ASPIRATED FLUID)
|
60 |
|
|
|
92 |
CELL COUNT(BRONCHIAL WASH)
|
60 |
|
|
|
93
|
CELL COUNT(CSF) |
100 |
|
|
|
94 |
CELL COUNT(PERICARDIAL FLUID) |
100 |
|
|
|
95
|
CELL COUNT(PLEURAL FLUID) |
100 |
|
|
|
96 |
CELL BLOCK
|
800 |
|
|
|
97
|
CELLCOUNT (SYNOVIAL FLUID) |
100 |
|
Appearance : Colourless
WBC : 0 - 200/µl
Neutrophils : Upto 20 %
Lymphocytes : Upto 15 %
Monocytes and Macrophages : Upto 65 %
|
|
98 |
Cephalosporin ( c7) - SPECIFIC IGE |
600 |
1 ML
|
Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
|
|
99
|
CERULOPLASMIN -SERUM |
400 |
1 ml
|
Male : 15 - 30 mg/dl
Female : 16 - 45 mg/dl
|
|
100 |
CERVICAL BIOPSY
|
500 |
|
|
|
101
|
CERVICAL SPINE AP
|
300 |
|
|
|
102 |
CERVICAL SPINE AP & LAT
|
500 |
|
|
|
103
|
CERVICAL SPINE LAT
|
300 |
|
|
|
104 |
CERVICAL SPINE OBLIQUE
|
300 |
|
|
|
105
|
CFTR - 4 COMMON MUTATION |
5000 |
|
|
|
106 |
Cheese(cheddar type) ( f 81)- SPECIFIC IgE |
600 |
|
Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
|
|
107
|
CHEST AP VIEW
|
300 |
|
|
|
108 |
CHEST For RIBS
|
300 |
|
|
|
109
|
CHEST LATERAL VIEW (RIGHT)
|
300 |
|
|
|
110 |
CHEST LATERAL VIEW (LEFT)
|
300 |
|
|
|
111
|
CHEST MEASURMENT
|
10 |
|
|
|
112 |
CHEST PA VIEW
|
300 |
|
|
|
113
|
Chicken (f 83) - SPECIFIC IGE |
600 |
1.0 ml
|
Less than 0.35 IU/mL: Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL: Very High Positive
|
|
114 |
Chicken feathers (e 85) - SPECIFIC - IgE |
600 |
|
Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
|
|
115
|
CHIKUNGUNYA IGM |
600 |
1 Ml
|
Chikungunya virus is transmitted by the bite of infected Aedes aegypti mosquito leading to Dengue like symptoms. Absence of IgM antibody does not exclude the possibility of Chikungunya infection. The test is a preliminary screening test and should not be interpreted in isolation, correlate clinically.
|
|
116 |
CHIKYNGUNYA BY RT PCR |
2000 |
|
|
|
117
|
CHLAMYDIA ANTIBODY IgM |
600 |
1 ml
|
Less than 0.90 A.I : Negative
0.90 - 1.10 A.I : Equivocal
More than 1.10 A.I : Positive
|
|
118 |
Chlamydia trachomatis IgA |
600 |
1 ml
|
Less than 0.80 Ratio: Negative
0.80 - 1.10 Ratio: Equivocal
More than 1.10 Ratio: Positive
Interpretation
Chlamydia trachomatis is the common cause of non-gonorrheal urethritis, lymphogranuloma venereum, trachoma and neonatal pneumonia . It also causes ophthalmologic infections. In males, epididymitis and Reiter syndrome occur. In Females, it causes pelvic inflamatory disease and endometritis.
Note: Serological results to chlamydia antibodies must be correlated with clinical history.
|
|
119
|
Chlamydia trachomatis IgG |
600 |
1 ml
|
Less than 0.80 Ratio : Negative
0.80 - 1.10 Ratio : Equivocal
More than 1.10 Ratio : Positive
Interpretation
Chlamydia trachomatis is the common cause of non-gonorrheal urethritis, lymphogranuloma venereum, trachoma and neonatal pneumonia . It also causes ophthalmologic infections. In males, epididymitis and Reiter syndrome occur. In Females, it causes pelvic inflamatory disease and endometritis.
Note: Serological results to chlamydia antibodies must be correlated with clinical history.
|
|
120 |
CHLAMYDIA DNA BY PCR |
4000 |
|
|
|
121
|
CHLORIDE ( ASCITIC FLUID) |
200 |
0.5 ml
|
|
|
122 |
CHLORIDE ( CL - ) |
200 |
|
Pre mature : 95 - 110 mmol/L
0 - 30 Days : 98 - 113 mmol/L
Adult : 98 - 107 mmol/L
|
|
123
|
CHLORIDE ( CL - )- DIALYSIS FLUID |
200 |
|
|
|
124 |
CHLORIDES (CSF) |
200 |
|
118 - 132 mMol/L
|
|
125
|
CHOCOLATE (f 105) - SPECIFIC IGE |
600 |
1 ml
|
Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
|
|
126 |
CHOLESTEROL - SERUM |
150 |
0.5 ml
|
NCEP guidlines ATP III classification
(Coronary heart disease risk)
Child(upto19 yrs)
Less than 170 mg/dl : Desirable
170 - 199 mg/dl : Borderline High
>= 200 mg/dl : High
Adult(Above 19 yrs)
Less than 200 mg/dl : Desirable
200 - 239 mg/dl : Borderline High
>= 240 mg/dl : High
|
|
127
|
CHOLESTEROL(ASCITIC FLUID) |
150 |
|
|
|
128 |
CHOLINESTERASE |
600 |
1.00 ML
|
3.93 - 10.80 kU/L
Cholinesterase is also called pseudocholinesterase. The main indicators for measuring pseudocholinesterase are:
1 . Monitoring exposure to cholinesterase inhibitors
2. As a liver function test
3. Diagnosis of genetic variants
Decreased levels
1. Organophosphate poisoning
2. Liver diseases like Acute hepatitis, Cirrhosis & Metastatic carcinoma to liver
3. Malnutrition
|
|
129
|
Chromogranin A |
5000 |
|
Less than 100 ug/l
Chromagranin A is elevated in Chromagranin A secreting neuroendocrine tumours (NETs), such as Pheochromocytomas and carcinoids.
|
|
130 |
CHROMOSOME BREAKAGE SYNDROME |
6000 |
|
|
|
131
|
CHYLURIA |
100 |
10 ml
|
|
|
132 |
CIBD PROFILE ( Chronic Inflammatory Bowel Disease) |
5000 |
|
|
|
133
|
CK ( CPK - TOTAL) -SERUM |
300 |
0.5 ml
|
Infants :-
1 Day : < 712 U/L
2 - 5 Days : < 652 U/L
6 Days - 6 Months : < 295 U/L
7 - 12 Months : < 203 U/L
Children
1 - 3 Yrs : < 228 U/L
4 - 6 Yrs : < 149 U/L
Male
7 - 12 Yrs : < 247 U/L
13 - 17 Yrs : < 270 U/L
Female
7 - 12 Yrs : < 154 U/L
13 - 17 Yrs : < 123 U/L
Adult Male : 20 - 200 U/L
Adult Female : 20 - 180 U/L
|
|
134 |
CK - MB - MASS - SERUM |
500 |
1 ml
|
Male :UPTO 6.22 ng/ml
Female :UPTO 4.88 ng/ml
|
|
135
|
Cladosporium herbarum(m2)- SPECIFIC IgE |
600 |
1 ml
|
Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
|
|
136 |
CLAVICLE (LEFT)
|
300 |
|
|
|
137
|
CLAVICLE (RIGHT)
|
300 |
|
|
|
138 |
Clinical Exome Sequencing |
25000 |
|
|
|
139
|
CLL - TRISOMY 12 BY FISH |
3500 |
|
|
|
140 |
CLONIDINE STIMULATION TEST |
1000 |
|
|
|
141
|
Clopidogerel(Clopiret) Resistance Test |
1000 |
|
Less than 5 Ohm ; Shows Antiplatelet effect
More tah 5.1 Ohms : Shows resistance
|
|
142 |
CLOPIDOGREL - GENETIC TEST |
4000 |
|
|
|
143
|
Clostridium Difficile (Stool) |
1400 |
|
|
|
144 |
CLOT RETRACTION TIME
|
300 |
|
|
|
145
|
CLOTTING TIME |
50 |
|
3 - 10 Minutes
|
|
146 |
CME CHOLAMINES, PLASMA |
8000 |
|
|
|
147
|
CMV VIRAL LOAD BY RT PCR |
4000 |
|
|
|
148 |
CMV DNA BY PCR |
4000 |
|
|
|
149
|
COBALT |
2000 |
|
1.8 µg/L OR less
|
|
150 |
COCAINE(URINE) |
200 |
|
|
|
151
|
COCCYX AP & LAT
|
500 |
|
|
|
152 |
COCCYX LAT
|
300 |
|
|
|
153
|
Cockroach ( i6 ) - SPECIFIC IgE |
600 |
1 ml
|
Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
|
|
154 |
Cocksfoot(Dacctylis glomerata)( g3)- SPECIFIC IgE |
600 |
|
Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
|
|
155
|
COCONUT (f 36) - SPECIFIC IgE |
600 |
1 ml
|
Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
|
|
156 |
CODEINE (URINE) |
200 |
|
|
|
157
|
COELIAC DISEASE PROFILE |
4000 |
1 ml
|
|
|
158 |
Cold Agglutinins |
4000 |
|
|
|
159
|
COLLAGEN
|
2000 |
|
|
|
160 |
Colour
|
0 |
|
|
|
161
|
Common ragweed[Ambrorosia elatior](w1)- SPECI |
600 |
|
Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
|
|
162 |
COMPLEMENT -TOTAL(CH50) |
5000 |
|
31 - 60 U/ml
Complement, Total (CH50) - CH50 is a screening test for total complement activity.
Levels of complement may be depressed in genetic deficiency, liver disease, chronic glomerulonephritis, rheumatoid arthritis, hemolytic anemias, graft rejection, systemic lupus erythematosis, acute glomerulonephritis, subacute bacterial endocarditis and cryoglobulinemia.
Elevated complement may be found in acute inflammatory conditions, leukemia, Hodgkin's Disease, sarcoma, and Behcet's Disease.
|
|
163
|
CONE VIEW SELLA
|
300 |
|
|
|
164 |
CONJUCTIVAL SMEAR FOR GRAM'S STAIN
|
200 |
|
|
|
165
|
CONSULTATION
|
250 |
|
|
|
166 |
COOMBS TEST - DIRECT-AUTOMATED |
300 |
1 ML
|
|
|
167
|
COOMBS TEST - INDIRECT - AUTOMATED |
750 |
1 ml
|
|
|
168 |
COPPER |
500 |
1 ml
|
MALE : 70 - 140 microgm/dl
FEMALE : 80 - 155 microgm/dl
CHILDREN 6- 12 YRS : 80 - 190 microgm/dl
NEW BORNS : 20 - 70 microgm/dl
PREGNANT WOMEN: 118 - 302 microgm/dl
|
|
169
|
CORTISOL ( AM) |
500 |
1 ml
|
6 am - 10 am : 6.02 - 18.4 Microgm/dl
4 pm - 8 pm : 2.68 - 10.5 Microgm/dl
Cortisol levels are increased in Cushings Disease and Syndrome and External Steroid treatment.Combining with ACTH measurement will help in differentiating betwwen Primary and Secondary Hypercortisolism.
Lower Levels are seen in Addisons Disease and Sheehans Syndrome.
|
|
170 |
CORTISOL ( PM) |
500 |
1 ml
|
7 am - 10 am : 6.02 - 18.4 Microgm/dl
4 pm - 8 pm : 2.68 - 10.5 Microgm/dl
Cortisol levels are increased in Cushings Disease and Syndrome and External Steroid treatment.Combining with ACTH measurement will help in differentiating betwwen Primary and Secondary Hypercortisolism.
Lower Levels are seen in Addisons Disease and Sheehans Syndrome.
|
|
171
|
COVID IgG Antibody |
750 |
|
Less than 0.8 : Negative
>0.80 - <1.0 : Equivoval
More than or Equal to 1.0 : Positive
Interpretive notes :
=====================
This test is for Sero Survelliance only and not for Diagnosis.
A negative Report does not rule out COVID - 19 Infection.
A positive report confirms exposure/Infection with SARS Cov 2 Virus
The presence of Antibody may not protect against reinfection or new infection.
The report must be correlated with Clinical and Imaging Data
|
|
172 |
COVID Total Antibody (ROCHE) |
600 |
|
Less than 1.0 : Negative
1.0 to 1.2 : Equivocal
More than 1.2 : Positive
Interpretive notes :
=====================
This test is for Sero Survelliance only and not for Diagnosis.
A negative Report does not rule out COVID - 19 Infection.
A positive report confirms exposure/Infection with SARS Cov 2 Virus
The presence of Antibody may not protect against reinfection or new infection.
The report must be correlated with Clinical and Imaging Data
|
|
173
|
COVID 19 by Real Time RT PCR |
1200 |
|
|
|
174 |
COVID IgM Ab ( SARS CoV-2 IgM Ab) |
900 |
|
Interpretation :
Less than 10 AU/ml : Non Reactive
( Less infection Risk of SARS CoV-2)
More than 10 AU/ml : Reactive
( Early infection or High Risk of Infection)
The results must be clinically correlated with other Investigations ,
and Imaging Data.
|
|
175
|
Crab ( f 23)- SPECIFIC IgE |
600 |
|
Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
|
|
176 |
CRANIUM - USG
|
900 |
|
|
|
177
|
CREATININE - DIALYSIS FLUID |
100 |
|
|
|
178 |
CREATININE - PLEURAL FLUID |
150 |
|
|
|
179
|
CREATININE - SERUM |
150 |
0.5 ml
|
Premature Neonates : 0.29 - 1.04 mg/dl
Full Term Neonates : 0.24 - 0.85 mg/dl
2 - 12 Month : 0.17 - 0.42 mg/dl
1 - 3 yrs : 0.24 - 0.41 mg/dl
3 - 5 yrs : 0.31 - 0.47 mg/dl
5 - 7 yrs : 0.32 - 0.59 mg/dl
7 - 9 yrs : 0.40 - 0.60 mg/dl
9 - 11 yrs : 0.39 - 0.73 mg/dl
11 -13 yrs : 0.53 - 0.79 mg/dl
13 -15 yrs : 0.57 - 0.87 mg/dl
Adult :-
Male : 0.7-1.2 mg/dl
Female : 0.5-0.9 mg/dl
|
|
180 |
CREATININE CLEARANCE |
400 |
5 ml urine & 0.5 ml Serum
|
71 - 151 ml/min
|
|
181
|
CREATININE(ASCITIC FLUID) |
150 |
|
|
|
182 |
CRP (CSF) |
250 |
|
|
|
183
|
CRYOGLOBULIN - SERUM |
200 |
|
|
|
184 |
Cryoglobulins Qualitative |
1000 |
|
|
|
185
|
Cryptococcal Antigen Test |
1500 |
|
|
|
186 |
CRYPTOCOCCUS ANTIGEN - LATEX TEST |
600 |
0.5 ml
|
|
|
187
|
CSF ANALYSIS |
200 |
|
|
|
188 |
CSF FOR AFB STAIN |
200 |
|
|
|
189
|
CSF FOR GRAMS STAIN |
200 |
|
|
|
190 |
CT - Abdomen Complete -Plain
|
3000 |
|
|
|
191
|
CT - Abdomen Complete- Palin and Contrast
|
4000 |
|
|
|
192 |
CT - Abdomenal Angio
|
7000 |
|
|
|
193
|
CT - Aortic Angiogram
|
4000 |
|
|
|
194 |
CT - Both Legs Peripheral Angio
|
10000 |
|
|
|
195
|
CT - Brain -Plain and Contarst
|
2200 |
|
|
|
196 |
CT - Brain -Plain Study
|
2000 |
|
|
|
197
|
CT - Brain and Sinuses
|
1500 |
|
|
|
198 |
CT - Brain Angio
|
4000 |
|
|
|
199
|
CT - Carotid Angiogram
|
4000 |
|
|
|
200 |
CT - Cerebral Angiogram
|
4000 |
|
|
|
201
|
CT - Cervical Spine
|
2000 |
|
|
|
202 |
CT - Chest -Plain and Contrast
|
3000 |
|
|
|
203
|
CT - Chest - HRCT
|
2000 |
|
|
|
204 |
CT - Chest -Plain Study
|
2000 |
|
|
|
205
|
CT - Contrast Charges (ABD)
|
1200 |
|
|
|
206 |
CT - Contrast Charges (M)
|
1000 |
|
|
|
207
|
CT - Contrast Charges (S)
|
600 |
|
|
|
208 |
CT - Dorsal Spines
|
3300 |
|
|
|
209
|
CT - ELBOW
|
2000 |
|
|
|
210 |
CT - Foot
|
2500 |
|
|
|
211
|
CT - Inner Ear & Temporal Bones
|
1800 |
|
|
|
212 |
CT - Knee Joint
|
2800 |
|
|
|
213
|
CT - KUB
|
3000 |
|
|
|
214 |
CT - Lower Abdomen Plain & Contrast
|
3300 |
|
|
|
215
|
CT - Lower Abdomen- Plain
|
2500 |
|
|
|
216 |
CT - Lower Limb
|
2000 |
|
|
|
217
|
CT - Lumbar Spines
|
3300 |
|
|
|
218 |
CT - Neck
|
2600 |
|
|
|
219
|
CT - Orbits
|
2000 |
|
|
|
220 |
CT - Paranasal Sinuses
|
1400 |
|
|
|
221
|
CT - Pelvis
|
2000 |
|
|
|
222 |
CT - Peripheral Angiogram
|
4000 |
|
|
|
223
|
CT - Pulmonary Angiogram
|
4000 |
|
|
|
224 |
CT - Renal Angiogram
|
4000 |
|
|
|
225
|
CT - SCREENING
|
1000 |
|
|
|
226 |
CT - Sella
|
2000 |
|
|
|
227
|
CT - SHOULDER
|
2000 |
|
|
|
228 |
CT - SI Joints
|
2800 |
|
|
|
229
|
CT - Thoracic Spine
|
2500 |
|
|
|
230 |
CT - TM Joints
|
2800 |
|
|
|
231
|
CT - Upper Abdomen - Palin and Contarst
|
3300 |
|
|
|
232 |
CT - Upper Abdomen - Plain
|
2500 |
|
|
|
233
|
CT - WRIST
|
2000 |
|
|
|
234 |
Cucumber(f244) - SPECIFIC IgE |
600 |
|
Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
|
|
235
|
Cultivate oat[Avena sativa]( g14)- SPECIFIC IgE |
600 |
|
Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
|
|
236 |
Cultivate wheat [Tricum aestivum]( g15)- SPECIFIC |
600 |
|
Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
|
|
237
|
CULTURE & SENSITIVITY
|
400 |
|
|
|
238 |
CULTURE & SENSITIVITY - VITEK
|
720 |
|
|
|
239
|
CULTURE & SENSITIVITYY
|
400 |
|
|
|
240 |
CYCLOSPORINE |
2500 |
2 ml
|
Post Kidney Transplant Trough Level :
Adults:
0-3 Months : 175 - 200 ng/ml
3-6 MOnths : 150 - 200 ng/ml
6-12 Months: 100 - 125 ng/ml
> 12 Months: 75 - 100 ng/ml
Post Liver Transplant Trough Levels :
0-6 Months : 150 -200 ng/ml
> 6 Months : 100 -150 ng/ml
Toxic Level Post Transplant :
1st Month : More than 500 ng/ml
2nd Month : More than 250 ng/ml.
Note : The levels are given as a guidance only. It may vary in a particular patient with Transplant Type, Other Medications ,and protocols.Samples should be drawn immediately prior to the next dose, for trough Level
|
|
241
|
CYFRA |
1500 |
|
|
|
242 |
CYSTATIN C |
500 |
|
20 to 50 years: 0.47 - 1.09 mg/l
|
|
243
|
CYSTICERCOSIS AB IGG |
750 |
1 ml
|
Less than 9.0 : Negative
9.0 - 11.0 : Equivocal
More than 11.0: Positive
|
|
244 |
CYSTICERCOSIS AB IGM |
750 |
1 ml
|
Less than 0.9 : Negative
0.9 - 1.1 : Equivocal
More than 1.1 : Positive
|
|
245
|
CYSTICERCOSIS ANTIBODY IGM (CSF) |
400 |
|
|
|
246 |
CYSTICERCOSIS ANTIBODY IGG(CSF) |
400 |
|
|
|
247
|
CYTOLOGY
|
900 |
|
|
|
248 |
CYTOLOGY ( FNAC - 1 SMEAR)
|
500 |
|
|
|
249
|
CYTOLOGY FOR MALIGNANT CELLS
|
900 |
|
|
RT-PCT Lab @ Purasawalkam
No.935, P.H.Road, Purasawalkam,
(Next to Blue Diamond Hotel)
9345612448, 9345650993